Query the merits of embryo editing for reproductive research now
By Insoo Hyun & Catherine Osborn,
Nature Biotechnology
| 11. 09. 2017
To the Editor:
Recently, a team from the United States used CRISPR–Cas9 on viable human embryos to correct a gene mutation that causes hypertrophic cardiomyopathy, a heritable heart condition in which the ventricle walls thicken to hinder proper blood flow1. For many, this announcement brings closer to reality the prospect of editing disease-associated mutations in fertility clinic embryos intended for reproductive use. The study certainly raises many scientific uncertainties and questions. But we contend that it also brings to light some questionable value assumptions that have largely flown under the radar in the social discourse around embryo editing. Here, we call attention to some of these assumptions and suggest that additional human embryo editing research may not be adequately justified until these issues have at least been openly acknowledged and debated. To be clear, our discussion is meant to apply only to 'preclinical' embryo editing research: that is, to corrective nuclear genome editing research performed in vitro with an eye toward eventual reproductive use under favorable regulatory circumstances. Our points do not necessarily apply to human embryonic genome...
Related Articles
By Annika Inampudi, Science | 08.01.2025
In June, Sara* received a message asking whether she wanted to continue to participate in a massive, multicenter research project led by scientists at Aarhus University in Denmark. The iPsych study, the message said, had sequenced her genetic data from...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Riley Beggin and Jeff Stein, The Washington Post | 08.03.2025
The White House does not plan to require health insurers to provide coverage for in vitro fertilization services, two people with knowledge of internal discussions said, even though the idea was one of President Donald Trump’s key campaign pledges.
Last...